Two New Medication Insight Reports for 23andMe+ Members

Most of us have a minimum of one genetic variant which will alter how our our bodies course of sure generally prescribed medicines. But, only a few of us learn about it.

That’s as a result of genetic testing for these variants, often known as pharmacogenetic testing, is uncommon. However these genetic variations can influence how an individual responds to sure prescribed medicines. 

CYP2C19 Drug Metabolism Medicine Insights

This week 23andMe launched two new Medicine Perception reviews* as a part of our 23andMe+ Membership. The membership affords greater than ten new reviews and options all through the calendar 12 months giving members even deeper insights into their well being. 23andMe stays the primary and solely direct-to-consumer firm with FDA-authorized pharmacogenetic reviews.

Our two new reviews present medicine insights on how an individual’s CYP2C19 metabolizer profile might influence citalopram and clopidogrel remedy. The reviews have a look at clopidogrel, a blood thinner, and an antidepressant, citalopram. About 22 million individuals within the US are prescribed citalopram.[1] About 20 million have prescriptions for clopidogrel.[2] 23andMe’s FDA clearance of those new reviews additionally removes the necessity for confirmatory testing in a medical setting for particular CYP2C19 outcomes. The reviews explicitly state that prospects ought to seek the advice of their healthcare supplier earlier than making any modifications to their medicines. 

The CYP2C19 gene offers the directions for making the CYP2C19 enzyme, which helps the liver course of (or “metabolize”) essential medicines. The enzyme additionally helps to course of different medicines equivalent to over-the-counter remedies for acid reflux disease and ulcers, known as proton pump inhibitors. 

Final 12 months 23andMe in collaboration with UCSF printed analysis confirming simply how frequent a few of these variants are. Our analysis signifies that for about 30 % of our prospects, clopidogrel shall be “seemingly much less efficient.” For East Asian and South Asian prospects, it’s greater than half who’ll see that consequence. About 3 % of consumers have an “elevated probability of negative effects” consequence for citalopram. Amongst East Asians and South Asians the proportion is between 10 % and 12 %.

Actionable Outcomes

These new reviews are a part of 23andMe’s bigger providing of Pharmacogenetic Experiences* on three genes that influence a complete of 11 medicines. Collectively they provide 23andMe+ members a brand new class of reviews, giving them deeper perception into their well being. The outcomes are among the many most extremely actionable genetic reviews shoppers can obtain. 

It has lengthy been identified that genetics influences why individuals reply in a different way to sure medicines. However it is extremely uncommon for individuals to find out about these variations earlier than they’ve already been prescribed a drugs.  

The research by researchers from 23andMe in collaboration with UCSF discovered that the majority of people have a minimum of one genetic variant within the CYP2C19 gene that impacts how the physique processes sure medicines, together with clopidogrel and citalopram. Earlier this 12 months, a meta-analysis showed that sufferers with loss-of-function variants within the CYP2C19 gene had a 30 % discount in ischemic occasions — together with coronary heart assaults and strokes — when handled with various antiplatelet medicines, together with ticagrelor or prasugrel, versus clopidogrel. 

Our personal analysis signifies that 70 % of 23andMe prospects would obtain a doubtlessly actionable consequence from our pharmacogenetic reviews.[3]

Information is Energy

In terms of medicines, we all know that one dimension doesn’t essentially match all. Completely different individuals might reply in a different way to the identical drugs resulting from elements like their age, weight, liver and kidney operate, weight loss plan, and even different medicines they is perhaps taking.

And we additionally know that for a lot of medicines, genetic elements additionally play an essential function. By way of our analysis and thru the work of different scientists we’ve realized how frequent it’s for individuals to have genetic variants that have an effect on how we metabolize sure medicines. Individuals may doubtlessly profit from realizing that they metabolize some medicines in a different way than others.

23andMe’s Pharmacogenetic Experiences provide shoppers an opportunity to find out about these variations, after which to share that info with their healthcare supplier in order that they’re higher capable of prescribe the precise drugs on the proper dose. Clients shouldn’t use their outcomes to start out, cease or change their medicines with out first consulting their healthcare supplier. 

In case you are not but a 23andMe+ member you’ll find out extra here.

References:


*23andMe PGS Pharmacogenetic reviews: The 23andMe take a look at makes use of qualitative genotyping to detect 3 variants within the CYP2C19 gene, 2 variants within the DPYD gene and 1 variant within the SLCO1B1 gene within the genomic DNA of adults from saliva for the aim of reporting and decoding details about the processing of sure therapeutics to tell discussions with a healthcare skilled. It doesn’t describe if an individual will or won’t reply to a specific therapeutic and doesn’t describe the affiliation between detected variants and any particular therapeutic. Our CYP2C19 Pharmacogenetic report offers sure details about variants related to metabolism of some therapeutics and offers interpretive drug info concerning the potential impact of citalopram and clopidogrel remedy. Outcomes for SLCO1B1 and DPYD and sure CYP2C19 outcomes ought to be confirmed by an unbiased genetic take a look at prescribed by your personal healthcare supplier earlier than taking any medical motion.  Warning: Take a look at info shouldn’t be used to start out, cease, or change any course of therapy and doesn’t take a look at for all doable variants which will have an effect on metabolism or protein operate. The PGS take a look at is just not an alternative choice to visits to a healthcare skilled. Making modifications to your present routine can result in dangerous negative effects or lowered meant advantages of your medicine, subsequently seek the advice of together with your healthcare skilled earlier than taking any medical motion. For essential info and limitations concerning Pharmacogentic reviews, go to www.23andme.com/test-info.

 

The put up Two New Medication Insight Reports for 23andMe+ Members appeared first on 23andMe Blog.

Powered by WPeMatico